Updated 12 sec ago · auto-refreshing
Trending claims
The fastest-moving factual assertions across the open web, ranked by velocity and weighted by credibility.
The drug daraxonrasib, recently approved by the FDA, doubled life expectancy to over 13 months for certain metastatic pancreatic cancer patients in a clinical trial, compared to under 7 months for those on chemotherapy.
Dr. Anna Berkenblit is the chief scientific and medical officer of the Pancreatic Cancer Action Network.
The author's brother Darrell was 62 when he died, and his pancreatic cancer was diagnosed after it had already spread.
Genetic counselor Danielle Hoffman stated that a negative genetic test result does not rule out a person's hereditary cancer risk.
Dr. Aimee Lucas's expertise includes early detection of pancreatic cancer in patients with a family history of the disease.
An MRI scan revealed a benign lesion on the author's pancreas, which Dr. Aimee Lucas said was not unusual for his family history.
The author's brother, Larry, was a Navy captain who died in the Pentagon on September 11, 2001.
The author was one of seven boys raised in Elgin, Nebraska, a town with a population of about 900.
One of the author's brothers survived colon cancer in the 1990s, and another brother survived both skin and throat cancer.
The author's genetic tests showed no indication of a genetic link to pancreatic cancer.
The author, Mark S. Getzfred, worked in journalism for 47 years before retiring from The New York Times in 2026.
Dr. Michael Murray is the clinical director for the Institute for Genomic Health at Mount Sinai Health System.
The American Cancer Society estimates for 2026 that about 67,530 Americans will be diagnosed with pancreatic cancer and about 52,740 will die from it.
An older brother of the author died of pancreatic cancer in August 2024.
The author's father died from colon and lung cancer in the early 1970s.
The author's younger brother died of pancreatic cancer in April 2023.
Mark S. Getzfred retired after working for 27 years as an editor at The New York Times.
A third brother of the author died of pancreatic cancer in February 2026.
In the U.S., pancreatic cancer is the third-leading cause of cancer-related deaths, following lung and colorectal cancers.
The author, Mark S. Getzfred, lost three brothers to cancer.